Abstract
Rituximab (RTX) therapy has shown promising results in Graves' disease (GD), with or without ophthalmopathy. We examined the occurrence of adverse events in GD patients treated with RTX.
| Original language | English |
|---|---|
| Journal | Journal of Endocrinological Investigation |
| Volume | 34 |
| Issue number | 7 |
| Pages (from-to) | e163-7 |
| ISSN | 0391-4097 |
| DOIs | |
| Publication status | Published - 2011 |
Fingerprint
Dive into the research topics of 'Systemic adverse events following rituximab therapy in patients with Graves' disease'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS